Our Stories

Proteomics in Action: When Cancer Comes Back


EVERY patient's cancer is different. Yet when treatment stops working, physicians are often left searching for new answers. Proteomics is helping change that by providing a deeper understanding of disease biology and revealing insights that can inform more personalized treatment decisions. As advances in mass spectrometry and protein analysis continue to accelerate, researchers are uncovering new opportunities to better understand disease and translate those discoveries into patient care

 

In this edition of Proteomics in Action, Dr. Thomas Conrads, director of Women's Health Research at Inova Health System, shares how proteomics is becoming an important part of precision oncology. From molecular tumor boards to proteomic-guided treatment decisions, he explains how researchers and clinicians are working together to better understand recurrent cancers and identify new therapeutic opportunities for patients.

 

Dr. Conrads' work reflects the impact that collaboration, scientific innovation, and advanced technologies can have on healthcare. It also illustrates how Thermo Fisher Scientific is helping enable researchers around the world to generate the insights that are advancing precision medicine and bringing new hope to patients and their families.